FRAZIER MANAGEMENT LLC holdings history

Add to watchlist

73 is the total number of securities FRAZIER MANAGEMENT LLC has owned. The longest FRAZIER MANAGEMENT LLC has owned a single stock is 21 quarters.

FRAZIER MANAGEMENT LLC historical holdings. Includes current and past holdings.
Period Weighting Quarter
TickerNameLongestShortestMin.Avg.Max.FirstLatest↓ Count
COLL COLLEGIUM PHARMACEUTIC...21211.45%10.19%36.98%Q4 2015Q4 202021
ANAB ANAPTYSBIO INC20201.49%25.56%63.70%Q1 2017Q4 202120
CDTX CIDARA THERAPEUTICS INC20200.34%3.95%17.18%Q4 2015Q3 202020
IOVA IOVANCE BIOTHERAPEUTIC...19192.57%5.73%13.75%Q2 2017Q4 202119
ALNA ALLENA PHARMACEUTICALS...18180.08%3.39%11.87%Q4 2017Q1 202218
ALPN ALPINE IMMUNE SCIENCES...18180.84%2.85%9.10%Q3 2017Q4 202118
APTX APTINYX INC15150.35%4.23%16.92%Q2 2018Q4 202115
KRYS KRYSTAL BIOTECH INC14142.01%5.28%9.72%Q3 2018Q4 202114
GRTS GRITSTONE ONCOLOGY INC14140.49%3.48%8.22%Q3 2018Q4 202114
SRRA SIERRA ONCOLOGY INC12120.47%3.32%6.63%Q1 2017Q4 201912
ITRM ITERUM THERAPEUTICS PLC12120.12%1.49%3.40%Q2 2018Q1 202112
FOLD AMICUS THERAPEUTICS INC11116.07%11.17%16.26%Q4 2015Q2 201811
SRRA SIERRA ONCOLOGY INC10100.19%19.32%100.00%Q1 2020Q2 202210
MIRM MIRUM PHARMACEUTICALS INC10104.38%7.00%14.67%Q3 2019Q4 202110
PHAT PHATHOM PHARMACEUTICAL...998.82%18.87%38.04%Q4 2019Q4 20219
RXDX IGNYTA INC992.93%6.41%11.53%Q4 2015Q4 20179
TBIO TRANSLATE BIO INC992.47%3.89%6.76%Q2 2019Q2 20219
NABRIVA THERAPEUTICS PLC990.20%1.46%2.66%Q3 2018Q3 20209
ETTX ENTASIS THERAPEUTICS H...990.04%1.40%2.69%Q3 2018Q3 20209
ARQT ARCUTIS BIOTHERAPEUTIC...8813.47%23.68%35.62%Q1 2020Q4 20218
PASG PASSAGE BIO INC882.45%7.04%12.02%Q1 2020Q4 20218
SNDX SYNDAX PHARMACEUTICALS...881.23%2.26%4.67%Q1 2020Q4 20218
PCVX VAXCYTE INC773.66%5.54%10.24%Q2 2020Q4 20217
TRILLIUM THERAPEUTICS INC771.08%2.85%4.40%Q1 2020Q3 20217
ISEE IVERIC BIO INC771.06%1.58%2.39%Q2 2020Q4 20217
SYBX SYNLOGIC INC770.20%1.49%2.25%Q1 2018Q3 20197
KZR KEZAR LIFE SCIENCES INC770.06%0.92%1.58%Q2 2018Q4 20197
BLCM BELLICUM PHARMACEUTICA...770.23%0.78%1.61%Q2 2018Q4 20197
MLND MILLENDO THERAPEUTICS INC660.84%2.93%5.04%Q4 2018Q1 20206
ADVM ADVERUM BIOTECHNOLOGIE...660.52%1.37%2.64%Q4 2019Q1 20216
RGNX REGENXBIO INC660.43%0.87%1.26%Q3 2020Q4 20216
DNAI PRONAI THERAPEUTICS INC551.95%6.47%13.75%Q4 2015Q4 20165
TARS TARSUS PHARMACEUTICALS...552.44%3.95%6.10%Q4 2020Q4 20215
STRO SUTRO BIOPHARMA INC551.67%1.89%2.22%Q4 2020Q4 20215
FLACU FRAZIER LIFESCIENCES A...551.15%1.23%1.39%Q4 2020Q4 20215
MTEM MOLECULAR TEMPLATES INC550.42%0.83%1.39%Q4 2020Q4 20215
FRLN FREELINE THERAPEUTICS ...550.15%0.53%0.77%Q3 2020Q3 20215
SRRK SCHOLAR ROCK HLDG CORP550.30%0.47%0.63%Q4 2020Q4 20215
EPZM EPIZYME INC550.14%0.43%0.61%Q4 2020Q4 20215
BLU BELLUS HEALTH INC NEW550.21%0.31%0.40%Q3 2020Q3 20215
NABRIVA THERAPEUTICS PLC550.02%0.05%0.08%Q4 2020Q4 20215
TBRA TOBIRA THERAPEUTICS INC4411.21%25.85%52.04%Q4 2015Q3 20164
LBIO LION BIOTECHNOLOGIES INC445.00%10.32%19.14%Q2 2016Q1 20174
RCKT ROCKET PHARMACEUTICALS...440.33%0.77%1.08%Q1 2020Q4 20204
ACRS ACLARIS THERAPEUTICS INC440.46%0.76%1.41%Q1 2021Q4 20214
EPIX ESSA PHARMA INC440.23%0.60%0.83%Q1 2021Q4 20214
AVDL AVADEL PHARMACEUTICALS...440.36%0.53%0.75%Q1 2021Q4 20214
IMVT IMMUNOVANT INC440.25%0.42%0.65%Q1 2021Q4 20214
GRTX GALERA THERAPEUTICS INC440.16%0.18%0.22%Q4 2020Q3 20214
GKOS GLAUKOS CORP3320.18%24.69%27.02%Q4 2015Q2 20163
KDNY CHINOOK THERAPEUTICS INC331.43%2.04%2.98%Q2 2021Q4 20213
AUTL AUTOLUS THERAPEUTICS PLC331.40%1.58%1.85%Q2 2021Q4 20213
CRDF CARDIFF ONCOLOGY INC330.22%0.45%0.79%Q3 2020Q1 20213
VTVT VTV THERAPEUTICS INC330.17%0.20%0.23%Q1 2020Q3 20203
BELLICUM PHARMACEUTICA...330.06%0.06%0.07%Q1 2020Q3 20203
IMAGO BIOSCIENCES INC224.76%5.09%5.42%Q3 2021Q4 20212
CRNX CRINETICS PHARMACEUTIC...221.43%2.23%3.03%Q3 2021Q4 20212
VRDN VIRIDIAN THERAPEUTICS INC221.98%2.14%2.29%Q3 2021Q4 20212
BCYC BICYCLE THERAPEUTICS PLC221.47%2.04%2.60%Q3 2021Q4 20212
TYRA BIOSCIENCES INC221.35%1.56%1.76%Q3 2021Q4 20212
REPL REPLIMUNE GROUP INC221.17%1.26%1.36%Q3 2021Q4 20212
GRCL GRACELL BIOTECHNOLOGIE...220.77%0.86%0.94%Q3 2021Q4 20212
KALV KALVISTA PHARMACEUTICA...220.22%0.77%1.33%Q3 2021Q4 20212
NERV MINERVA NEUROSCIENCES INC220.01%0.08%0.16%Q3 2020Q4 20202
PARDES BIOSCIENCES INC113.10%3.10%3.10%Q4 2021Q4 20211
ARMO ARMO BIOSCIENCES INC111.86%1.86%1.86%Q1 2018Q1 20181
SLN SILENCE THERAPEUTICS PLC111.63%1.63%1.63%Q4 2021Q4 20211
MRUS MERUS N V111.37%1.37%1.37%Q4 2021Q4 20211
TCDA TRICIDA INC111.31%1.31%1.31%Q4 2021Q4 20211
COGT COGENT BIOSCIENCES INC111.17%1.17%1.17%Q4 2021Q4 20211
ARVN ARVINAS INC111.04%1.04%1.04%Q4 2021Q4 20211
SBTX SILVERBACK THERAPEUTIC...110.13%0.13%0.13%Q4 2020Q4 20201
No remaining holdings110.00%0.00%0.00%Q3 2022Q3 20221
 Download

The securities at the top of the list , including COLLEGIUM PHARMACEUTICAL INC, ANAPTYSBIO INC, and CIDARA THERAPEUTICS INC, are the highest-conviction holdings of FRAZIER MANAGEMENT LLC.

The conviction is calculated by counting the number of quarters a security has been reported by FRAZIER MANAGEMENT LLC. The higher the number, the higher the conviction and longer the holding period.

This page lists all the securities that FRAZIER MANAGEMENT LLC owns currently or has owned in the past.